I must admit though that I am not a great market timer. I invest based on the science, and buy and hold for the long term. So who knows if CLSN will correct down some? As i previously mentioned, look at INFI-- it's been a 6-bagger this year, without correcting!!
Same here. I recently have been following it. My question: is it going to be better than AEZS-108?
Look at the market caps. AEZS is one quarter the market cap of CLSN. Why should I invest in CLSN instead?
Also, I have enough bios in the cancer area (snta, thld, and gale), so I'm gunshy about buying more. Lol.